Jeffrey S. T.
About Jeffrey S. T.
Jeffrey S. T. serves as the Managing Director of Healthcare Investment Banking at Piper Sandler in Boston, Massachusetts, where he has worked since 2021. He has extensive experience in corporate development and investment banking, with a strong background in the healthcare sector.
Work at Piper Sandler
Jeffrey S. T. serves as the Managing Director of Healthcare Investment Banking at Piper Sandler. He has held this position since 2021, contributing to the firm's operations from its Boston, Massachusetts office. In this role, he focuses on providing strategic advisory services and executing transactions within the healthcare sector.
Education and Expertise
Jeffrey S. T. holds a Bachelor of Science in Biochemistry from the University of Michigan and an MBA in Finance from the UNC Kenan-Flagler Business School. His educational background supports his extensive expertise in healthcare investment banking, where he possesses a strong knowledge base across various healthcare sectors, including pharmaceuticals, biotech, and medical devices.
Background
Prior to his current role at Piper Sandler, Jeffrey S. T. held several significant positions in the healthcare industry. He was the Chief Corporate Development Officer at LABORIE from 2017 to 2021 and served on the Board of Directors for Urotronic, Inc. and Advanced Instruments, LLC. His career includes experience in both scientific and corporate development roles, providing a comprehensive understanding of the healthcare landscape.
Achievements
Throughout his career, Jeffrey S. T. has accumulated substantial transactional experience, having closed approximately 65 transactions with a cumulative deal value exceeding $35 billion. His work spans various deal sizes and types, including equity, joint ventures, and acquisitions, reflecting his capability in navigating complex financial landscapes within the healthcare sector.
Previous Employment History
Jeffrey S. T. has a diverse employment history that includes roles such as Senior Vice President of Corporate Development at Smith & Nephew and Managing Director of Business Development at GE Healthcare. He also worked as a Scientist in Cardiovascular Drug Discovery at Eli Lilly and as an Associate in Healthcare Investment Banking at Banc of America Securities, showcasing his extensive experience in both scientific and financial aspects of the healthcare industry.